期刊
HISTOPATHOLOGY
卷 56, 期 6, 页码 727-739出版社
WILEY
DOI: 10.1111/j.1365-2559.2010.03544.x
关键词
classical NF-kappa B pathway; ovarian cancer; prognosis
Aims: Functional studies have demonstrated that nuclear factor (NF)-kappa B promotes tumour progression in ovarian cancer cells. However, surprisingly little is known of the expression of effectors of the NF-kappa B pathway in human ovarian cancer in vivo. Methods and results: Immunohistochemistry and in situ hybridization revealed that in a cohort of 85 primary ovarian carcinomas, total p65 expression was inversely correlated to nuclear and cytoplasmic phospho-I kappa B alpha (P = 0.002 and P = 0.05, respectively), and I kappa B alpha mRNA expression (P = 0.032). In contrast, phospho-p65 expression was paralleled by the expression of nuclear (P = 0.027) and cytoplasmic phospho-I kappa B alpha (P = 0.01). Total p65 expression was an adverse prognostic factor for overall survival (P = 0.018). In contrast, total I kappa B alpha and phosphorylated nuclear and cytoplasmic I kappa B alpha expression were favourable prognostic markers (P = 0.001, P = 0.031, P = 0.001, respectively). Cytoplasmic phospho-I kappa B alpha expression remained a significant prognostic factor on multivariate analysis (P = 0.010). In cultured, stimulated OVCAR-3 ovarian cancer cells the cytoplasmic retranslocation of p65 was delayed by inhibition of the nuclear membrane transporter chromosomal region maintenance/exportin1 protein (CRM1). A positive association of p65 and CRM1 expression was demonstrated in ovarian cancer tissue (P < 0.0001). Conclusions: Total and phosphorylated I kappa B alpha protein expression might serve as markers for NF-kappa B activation in human ovarian carcinoma. Cytoplasmic localization of p65 may be related to deregulated nucleocytoplasmic transport in carcinomas overexpressing CRM1.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据